TAG:
pathology consultant
Pathology PPM Appears Ready To Hit Marketplace
CEO SUMMARY: After several months of delays, Physician Solutions recruited a new CEO and completed arrangements to receive $20 million in venture capital funding. These two milestones mean that the pathology-based physician practice management company will soon be ready to launch formal b…
“February 9, 1998 Intelligence: Late Breaking Lab News”
Brian Carr and Haywood Cochrane’s Pathology Consultants of America (PCA) is wasting no time. On January 19 the Nashville-based company announced the formal launch of operations. (See TDR, January 19, 1998.) This was followed by another announcement 15 days later that PCA h…
New Pathology PPM Hits Competitive Marketplace
CEO SUMMARY: Nashville hatched another pathology-based physician practice management firm. This newest competitor was capitalized by pathologists. Its arrival in the competitive marketplace signals further changes to the traditional practice of pathology. Increasingly, it will be business…
To Protect Pathology Profits: Understand Managed Care
CEO SUMMARY: On November 8, 1997, THE DARK REPORT convened a private symposium restricted only to pathologists. The sole purpose of this event was to identify how pathologists could preserve and enhance their income. Within the confidential setting of a plush resort in Scottsdale, Arizona…
Pathology As A Business: Experts Highlight Issues
CEO SUMMARY: A select group of business-minded pathologists broke new ground last week in Scottsdale, Arizona. Candid discussion about the profession’s most sensitive issues provoked a variety of strategies. Among the topics were declining reimbursement, arbitrary contract pricing for A…
1997’s Most Interesting Laboratory Innovators
CEO SUMMARY: During the next year, the clinical laboratory industry faces some of its toughest business challenges in history. Here are eight individuals who possess a unique combination of spirit and grit and seek to transform their laboratory organizations into winners. E…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.